Skip to content

Jay Venkatesan, Director at Serina Therapeutics, bought SER on May 22, 2026

Data as of Oct 16

▲ BUY$1K589 shares at $1.78Jay Venkatesan DirectorSER Serina Therapeutics, Inc.
Watch SER
Traded
May 22, 2026
Disclosed
Jun 22, 2026
Filed
31 days after the trade · late

Form 4s are due within two business days.

Official filing (SEC Form 4) ↗

The price around the disclosure

Jay Venkatesan, Director at Serina Therapeutics, bought SER on May 22, 2026TRADEDDISCLOSED
SERSimilar stocks (S&P 500 (SPY)), rebased to SER's price on the disclosure day
SER since disclosure
−9.0%
Similar stocks (SPY) since disclosure
+2.5%
S&P 500 (SPY)

Change in closing price from Jun 22, 2026 (the first trading day on or after disclosure) to Oct 16, 2026. Dividends excluded. Not a return anyone earned.

Our take

None of our tested rules fired on this trade.

See every trade on SER →